A third patient (UPN126), previously diagnosed with primary myelofibrosis associated with a JAK2-mutation, transformed to a secondary AML 2 years after the initial diagnosis (Fig. 6E). This evidence concerns the gene JAK2 and acute myeloid leukemia.